A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
- Conditions
- Meningitis, CryptococcalHIV Infections
- Registration Number
- NCT00002068
- Lead Sponsor
- Pfizer
- Brief Summary
To compare the safety and effectiveness of fluconazole and amphotericin B, alone or in combination with flucytosine, as treatment for acute cryptococcal meningitis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (8)
Davies Med Ctr
🇺🇸San Francisco, California, United States
Christiana Hosp / Med Ctr of Delaware
🇺🇸Wilmington, Delaware, United States
Univ of South Florida
🇺🇸Tampa, Florida, United States
Univ of Maryland / Inst of Human Virology
🇺🇸Baltimore, Maryland, United States
Henry Ford Hosp
🇺🇸Detroit, Michigan, United States
Harlem AIDS Treatment Group / Harlem Hosp Ctr
🇺🇸New York, New York, United States
Univ of Tennessee
🇺🇸Memphis, Tennessee, United States
Saint Michael's Hosp
🇨🇦Toronto, Ontario, Canada
Davies Med Ctr🇺🇸San Francisco, California, United States